BridgeBio Pharma (BBIO) Earnings Date, Estimates & Call Transcripts $43.70 +0.88 (+2.04%) Closing price 07/3/2025 03:50 PM EasternExtended Trading$43.12 -0.59 (-1.34%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BridgeBio Pharma Earnings Summary BridgeBio Pharma posted Q1 2025 earnings on April 29, 2025, reporting an EPS of -$0.88, which beat the consensus estimate of -$1.00 by $0.12. Quarterly revenue fell 44.8% year-over-year to $36.74 million, below analyst estimates of $57.14 million. With a trailing EPS of -$3.53, BridgeBio Pharma's earnings are expected to grow next year, from ($3.67) to ($2.30) per share. Upcoming Q2 Earnings DateJul. 30After Market ClosesEstimatedConsensus EPS (Apr. 29) -$1.00 Actual EPS (Apr. 29) -$0.88 Beat By $0.12 Actual Revenue (Apr. 29) $36.74MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)BBIO Upcoming EarningsBridgeBio Pharma's next earnings date is estimated for Wednesday, July 30, 2025, based on past reporting schedules. Powered by Get BridgeBio Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BridgeBio Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBBIO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BBIO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. BridgeBio Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.01-$0.69-$0.85Q2 20252-$0.87-$0.76-$0.82Q3 20252-$0.84-$0.79-$0.82Q4 20252-$0.85-$0.60-$0.73 FY 2025 8 -$3.57 -$2.84 -$3.21 Q1 20261-$0.69-$0.69-$0.69Q2 20261-$0.60-$0.60-$0.60Q3 20261-$0.50-$0.50-$0.50Q4 20261-$0.32-$0.32-$0.32 BridgeBio Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/30/2025(Estimated)--------4/29/2025Q1 2025-$1.00-$0.88+$0.12-$0.88$57.14M$36.74M2/20/2025Q4 2024-$1.09-$1.31 -$0.22-$1.40$4.04M$5.88M8/1/2024Q2 2024-$1.00-$0.39+$0.61-$1.65$3.96M$2.17M5/2/2024Q1 2024-$0.40-$0.05+$0.35$0.10$140.06M$211.12M2/22/2024Q4 2023-$0.87-$0.96 -$0.09-$0.96$4.78M$1.74M11/2/2023Q3 2023-$0.86-$1.08 -$0.22-$1.08$5.29M$4.09M8/3/2023Q2 2023-$0.80-$0.98 -$0.18-$0.98$2.99M$1.60M BridgeBio Pharma Earnings - Frequently Asked Questions When is BridgeBio Pharma's earnings date? BridgeBio Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 30th, 2025 based off last year's report dates. Learn more on BBIO's earnings history. Did BridgeBio Pharma beat their earnings estimates last quarter? In the previous quarter, BridgeBio Pharma (NASDAQ:BBIO) reported ($0.88) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.00) by $0.12. Learn more on analysts' earnings estimate vs. BBIO's actual earnings. How can I listen to BridgeBio Pharma's earnings conference call? The conference call for BridgeBio Pharma's latest earnings report can be listened to online. Listen to Conference Call How can I read BridgeBio Pharma's conference call transcript? The conference call transcript for BridgeBio Pharma's latest earnings report can be read online. Read Transcript How much revenue does BridgeBio Pharma generate each year? BridgeBio Pharma (NASDAQ:BBIO) has a recorded annual revenue of $221.90 million. How much profit does BridgeBio Pharma generate each year? BridgeBio Pharma (NASDAQ:BBIO) has a recorded net income of -$535.76 million. BBIO has generated -$3.53 earnings per share over the last four quarters. What is BridgeBio Pharma's EPS forecast for next year? BridgeBio Pharma's earnings are expected to grow from ($3.67) per share to ($2.30) per share in the next year. More Earnings Resources from MarketBeat Related Companies ONC Earnings Results BNTX Earnings Results TEVA Earnings Results INSM Earnings Results SMMT Earnings Results ITCI Earnings Results GMAB Earnings Results RDY Earnings Results QGEN Earnings Results MRNA Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:BBIO) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BridgeBio Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
